All In Biotech

Free tool

FAERS Monitor: Salonpas

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022029 or its brand name (Salonpas, Menthol, Methyl Salicylate). Reports on generic versions are filed under their own applications.

Reports

37,817

Serious

29,306

77% of reports

Hospitalization

14,137

Death reported

7,326

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective8,004
  • pain7,680
  • fatigue7,245
  • rheumatoid arthritis6,543
  • rash6,293
  • abdominal discomfort6,172
  • off label use6,019
  • systemic lupus erythematosus6,006
  • alopecia5,903
  • glossodynia5,881
  • pemphigus5,836
  • swelling5,561
  • joint swelling5,406
  • hand deformity5,363
  • arthropathy5,355

Reports by year received

View as table
YearReports
2004432
2005490
2006454
2007606
2008749
2009561
2010794
20111,184
2012905
2013330
2014391
2015620
20161,082
20171,194
20181,762
20191,883
20202,343
20213,135
20223,363
20233,470
20245,038
20254,363
20262,666

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,016,342 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal5,836485.7469.61,506,946
hand deformitySignal5,363383.7371.21,211,557
glossodyniaSignal5,881197.8192.3849,873
systemic lupus erythematosusSignal6,006113.1110.2555,138
arthropathySignal5,35559.257.6277,476
swellingSignal5,56135.134.2173,878
rheumatoid arthritisSignal6,54334.033.2198,238
joint swellingSignal5,40626.025.4124,976
abdominal discomfortSignal6,17221.220.7115,364
alopeciaSignal5,90317.216.888,197
rashSignal6,2938.17.939,610
painSignal7,6807.06.940,392
fatigueSignal7,2455.25.125,387
off label useSignal6,0193.83.813,113
drug ineffectiveSignal8,0043.43.314,316

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.